Skip to main content
Cell Death & Disease logoLink to Cell Death & Disease
. 2024 Feb 14;15(2):142. doi: 10.1038/s41419-024-06519-7

Correction: Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers

François-Xavier Danlos 1,2,#, Claudia Grajeda-Iglesias 3,4,#, Sylvère Durand 3, Allan Sauvat 3, Mathilde Roumier 5, Delphine Cantin 6, Emeline Colomba 7, Julien Rohmer 5, Fanny Pommeret 7, Giulia Baciarello 7, Christophe Willekens 8, Marc Vasse 9, Frank Griscelli 10, Jean-Eudes Fahrner 1,2, Anne-Gaëlle Goubet 1,2, Agathe Dubuisson 1,2, Lisa Derosa 1,7,11, Nitharsshini Nirmalathasan 3, Delphine Bredel 1, Séverine Mouraud 1, Caroline Pradon 12, Annabelle Stoclin 13, Flore Rozenberg 14, Jérôme Duchemin 15, Georges Jourdi 15,16, Syrine Ellouze 15, Françoise Levavasseur 17, Laurence Albigès 7, Jean-Charles Soria 18, Fabrice Barlesi 7,19, Eric Solary 2,8,20, Fabrice André 2,7,21, Frédéric Pène 17,22, Félix Ackerman 5, Luc Mouthon 17,23, Laurence Zitvogel 1,2,11, Aurélien Marabelle 1,2,11,24, Jean-Marie Michot 8,24, Michaela Fontenay 15,17, Guido Kroemer 3,25,26,27,28,
PMCID: PMC10866964  PMID: 38355585

Correction to: Cell Death and Disease (2021) 10.1038/s41419-021-03540-y, published online 11 March 2021

In this article the Funding section has been added:

“European Union Horizon 2020 research project Oncobiome (grant number 825410)”

The original article has been corrected.


Articles from Cell Death & Disease are provided here courtesy of Nature Publishing Group

RESOURCES